STTK
Shattuck Labs IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$569.13M
P/E Ratio
—
EPS
$-0.70
Beta
1.29
52W High
$8.33
52W Low
$0.71
50-Day MA
$6.03
200-Day MA
$3.25
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Shattuck Labs Inc
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapies for the treatment of cancer and autoimmune diseases in the United States. The company is headquartered in Austin, Texas.
Fundamentals
| Revenue (TTM) | $1.00M |
| Gross Profit (TTM) | $-1.95M |
| EBITDA | $-47.74M |
| Operating Margin | -5143.00% |
| Return on Equity | -60.30% |
| Return on Assets | -35.30% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $1.30 |
| Price-to-Book | 6.91 |
| Price-to-Sales (TTM) | 569.13 |
| EV/Revenue | 493.49 |
| EV/EBITDA | -3.62 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -66.60% |
| Shares Outstanding | $75.58M |
| Float | $47.57M |
| % Insiders | 5.09% |
| % Institutions | 63.75% |
Historical Volatility
HV 10-Day
47.47%
HV 20-Day
56.63%
HV 30-Day
54.65%
HV 60-Day
66.19%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($12.00 target)
2
Strong Buy4
Buy1
HoldData last updated: 4/30/2026